基于相对效价质子泵抑制剂可互换使用
该研究分析在患者中开展至少5天固体剂型质子泵抑制剂(奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑、雷贝拉唑)并进行pH监测的随机临床试验数据,以奥美拉唑等效剂量和24小时pH>4时间百分比为指标比较不同给药频率的疗效,结论为基于效价质子泵抑制剂可互换使用,每日两次给药比增加每日一次剂量更有效。
要点
- 每日一次质子泵抑制剂强度增加(9-64 mg奥美拉唑等效剂量)使pH>4时间线性增加约10.0至15.6小时,更高剂量未进一步增加。
- 每日两次质子泵抑制剂使pH>4时间线性增加约15.8至21.0小时,每日三次与每日两次效果相似。
- 奥美拉唑和兰索拉唑30 mg与埃索美拉唑20 mg、雷贝拉唑20 mg功能等效。
核心结论
- 基于效价质子泵抑制剂可互换使用,每日两次给药比增加每日一次剂量更有效提高疗效。
研究设计与样本
- 分析在患者中开展至少5天固体剂型质子泵抑制剂(奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑、雷贝拉唑)并进行pH监测的随机临床试验数据。
主要发现
- 每日一次质子泵抑制剂强度增加(9-64 mg奥美拉唑等效剂量)使24小时pH>4时间从约10.0小时线性增加至15.6小时,更高剂量未进一步增加。
- 每日两次质子泵抑制剂使24小时pH>4时间从约15.8小时线性增加至21.0小时。
- 每日三次质子泵抑制剂与每日两次效果相似。
- 质子泵抑制剂成本差异大,但成本差异与效价无直接关系。
关键数值与推荐
- 奥美拉唑和兰索拉唑30 mg与埃索美拉唑20 mg、雷贝拉唑20 mg功能等效。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although proton pump inhibitors (PPIs) are widely used, their relative potency and ideal dosing regimens remain unclear. We analyzed data from randomized clinical trials that performed pH testing in patients receiving solid-dose PPI formulations (omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole) for a minimum of 5 days. We used omeprazole equivalency and the surrogate biomarker, percentage time pH > 4 over a 24-hour period (pH4time), to compare PPI effectiveness for different PPIs given once, twice, or 3 times daily. We found that increasing strength of once-daily PPIs (9-64 mg omeprazole equivalents) increased pH4time linearly from approximately 10.0 to 15.6 hours; higher doses produced no further increase in pH4time. Increasing the frequency to twice-daily PPI increased pH4time linearly, from approximately 15.8 to 21.0 hours. Three-times daily PPIs performed similarly to twice-daily PPIs. The costs of PPIs varied greatly, but the cost variation was not directly related to potency. We conclude that PPIs can be used interchangeably based on potency. Using twice-daily PPIs is more effective in increasing efficacy increasing once-daily PPI dosage. Omeprazole and lansoprazole (30 mg) and 20 mg of esomeprazole rabeprazole are functionally equivalent.
引用
- Graham DY, Tansel A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clin Gastroenterol Hepatol. 2017. PMID: 28964908. doi:10.1016/j.cgh.2017.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。